Revvity, Inc. 0KHE.L Stock
Revvity, Inc. Price Chart
Revvity, Inc. 0KHE.L Financial and Trading Overview
Revvity, Inc. stock price | 104.43 USD |
Previous Close | 115.78 USD |
Open | 0 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 169.7 USD |
Volume | 760 USD |
Avg. Volume | 1.8K USD |
Market Cap | 128.07M USD |
Beta (5Y Monthly) | 1.10669 |
PE Ratio (TTM) | 0.18850648 |
EPS (TTM) | 6.16 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0KHE.L Valuation Measures
Enterprise Value | 16.57B USD |
Trailing P/E | 0.18850648 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.042359285 |
Price/Book (mrq) | 1.8215101 |
Enterprise Value/Revenue | 5.481 |
Enterprise Value/EBITDA | 15.365 |
Trading Information
Revvity, Inc. Stock Price History
Beta (5Y Monthly) | 1.10669 |
52-Week Change | -19.89% |
S&P500 52-Week Change | 20.43% |
52 Week High | 169.7 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 124.5 USD |
200-Day Moving Average | 132.14 USD |
0KHE.L Share Statistics
Avg. Volume (3 month) | 1.8K USD |
Avg. Daily Volume (10-Days) | 106 USD |
Shares Outstanding | 111.24M |
Float | 115.03M |
Short Ratio | N/A |
% Held by Insiders | 0.26% |
% Held by Institutions | 86.25% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.28 |
Trailing Annual Dividend Yield | 0.24% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | January 1, 2023 |
Most Recent Quarter (mrq) | April 2, 2023 |
Next Fiscal Year End | January 1, 2024 |
Profitability
Profit Margin | 31.80% |
Operating Margin (ttm) | 21.56% |
Gross Margin | 59.85% |
EBITDA Margin | 35.67% |
Management Effectiveness
Return on Assets (ttm) | 2.76% |
Return on Equity (ttm) | 4.64% |
Income Statement
Revenue (ttm) | 3.02B USD |
Revenue Per Share (ttm) | 23.96 USD |
Quarterly Revenue Growth (yoy) | -29.89% |
Gross Profit (ttm) | 2.04B USD |
EBITDA | 1.08B USD |
Net Income Avi to Common (ttm) | 353.45M USD |
Diluted EPS (ttm) | 6.162 |
Quarterly Earnings Growth (yoy) | 221.80% |
Balance Sheet
Total Cash (mrq) | 2.46B USD |
Total Cash Per Share (mrq) | 19.62 USD |
Total Debt (mrq) | 4.51B USD |
Total Debt/Equity (mrq) | 56.14 USD |
Current Ratio (mrq) | 2.427 |
Book Value Per Share (mrq) | 63.77 |
Cash Flow Statement
Operating Cash Flow (ttm) | 460.06M USD |
Levered Free Cash Flow (ttm) | 1.02B USD |
Profile of Revvity, Inc.
Country | United Kingdom |
State | MA |
City | Waltham |
Address | 940 Winter Street |
ZIP | 02451 |
Phone | 781 663 6900 |
Website | https://www.revvity.com |
Industry | |
Sector(s) | |
Full Time Employees | 11000 |
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Q&A For Revvity, Inc. Stock
What is a current 0KHE.L stock price?
Revvity, Inc. 0KHE.L stock price today per share is 104.43 USD.
How to purchase Revvity, Inc. stock?
You can buy 0KHE.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Revvity, Inc.?
The stock symbol or ticker of Revvity, Inc. is 0KHE.L.
How many shares does Revvity, Inc. have in circulation?
The max supply of Revvity, Inc. shares is 1.1M.
What is Revvity, Inc. Price to Earnings Ratio (PE Ratio)?
Revvity, Inc. PE Ratio is 0.16947258 now.
What was Revvity, Inc. earnings per share over the trailing 12 months (TTM)?
Revvity, Inc. EPS is 6.16 USD over the trailing 12 months.